Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rautio

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Liver function and medroxyprogesterone acetate elimination in manA Rautio
The Pharmacogenomics Journal|March 12, 2003
Polymorphic CYP2A6 and its clinical and toxicological significanceA Rautio
IARC Scientific Publications|September 24, 1999
The CYP2A subfamily: function, expression and genetic polymorphismH Raunio, A Rautio, O Pelkonen
Diabetes Care|October 1, 1995
Ginseng therapy in non-insulin-dependent diabetic patientsE A Sotaniemi, E Haapakoski, A Rautio
Toxicology|April 27, 2000
CYP2A6: a human coumarin 7-hydroxylaseO Pelkonen, A Rautio, H Raunio, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Polymorphisms of CYP2A6 and its practical consequencesH Raunio, A Rautio, H Gullstén, et al.
IARC Scientific Publications|September 24, 1999
Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotypeO Pelkonen, H Raunio, A Rautio, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1982
Pericellular collagen in alcoholics with liver cirrhosisA J Arranto, A Rautio, E A Sotaniemi
Therapie|July 1, 1996
Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in manE A Sotaniemi, P Lumme, P Arvela, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy menP Mustajoki, S Mustajoki, A Rautio, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Liver function and medroxyprogesterone acetate elimination in manA Rautio
The Pharmacogenomics Journal|March 12, 2003
Polymorphic CYP2A6 and its clinical and toxicological significanceA Rautio
IARC Scientific Publications|September 24, 1999
The CYP2A subfamily: function, expression and genetic polymorphismH Raunio, A Rautio, O Pelkonen
Diabetes Care|October 1, 1995
Ginseng therapy in non-insulin-dependent diabetic patientsE A Sotaniemi, E Haapakoski, A Rautio
Toxicology|April 27, 2000
CYP2A6: a human coumarin 7-hydroxylaseO Pelkonen, A Rautio, H Raunio, et al.
British Journal of Clinical Pharmacology|October 27, 2001
Polymorphisms of CYP2A6 and its practical consequencesH Raunio, A Rautio, H Gullstén, et al.
IARC Scientific Publications|September 24, 1999
Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotypeO Pelkonen, H Raunio, A Rautio, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1982
Pericellular collagen in alcoholics with liver cirrhosisA J Arranto, A Rautio, E A Sotaniemi
Therapie|July 1, 1996
Age and CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in manE A Sotaniemi, P Lumme, P Arvela, et al.
Clinical Pharmacology and Therapeutics|July 1, 1994
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy menP Mustajoki, S Mustajoki, A Rautio, et al.
Pageof 6